MedTrace Logo

Revitalization of Damaged Skin Due to Chronic Skin Diseases

NCT03485560 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-04-02

No results posted yet for this study

Summary

Chronic skin disease lead to skin damage and disfiguring to the patient skin. Sometimes, achieving normal skin is not possible by the normal traditional treatment, this study is focusing on use of ACE CSD formula which is mixture of natural peptides and herbs. the main aim is to restore the normal skin appearance for the patient and control the episodes of flare.

Conditions

Interventions

COMBINATION_PRODUCT

ACE CSD

Topical application of the ACE CSD 4 times daily.

Sponsors & Collaborators

  • Ace Cells Lab Limited

    lead INDUSTRY

Principal Investigators

  • Dr. Diana Diana, MSc Dermatology · ACE cells Lab europe DOO

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2018-11-01
Completion
2019-01-01

Countries

  • Serbia
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03485560 on ClinicalTrials.gov